SCHEMBL12305478

SCHEMBL12305478

CCCCO[C@@H]1C(C)OC(c2cnc3c(N)ncnn23)[C@]1(C)OCCCC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12306914 0.87 — —
SCHEMBL14038378 0.86 POLRMT (0.31) —
SCHEMBL14140989 0.78 — —
SCHEMBL13392125 0.76 — —
SCHEMBL11924463 0.73 DOT1L (0.30) —
SCHEMBL13648870 0.71 — —
SCHEMBL13532213 0.71 PIK3CD (0.34) —
SCHEMBL10100148 0.71 — —
SCHEMBL12306916 0.71 PRMT5 (0.33) —
SCHEMBL18520959 0.70 GJB2 (0.33) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8012941-B2 Carba-nucleoside analogs for antiviral treatment GILEAD SCIENCES, INC. (US) 2011-09-06 — — US disclosed
US-20090317361-A1 CARBA-NUCLEOSIDE ANALOGS FOR ANTIVIRAL TREATMENT GILEAD SCIENCES, INC. (US) 2009-12-24 — — US disclosed
Send feedback